000972 Stock Overview
Engages in the production, processing, and sales of tomatoes in China.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 4/6 |
| Financial Health | 1/6 |
| Dividends | 0/6 |
Chalkis Health Industry Co., Ltd Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥2.75 |
| 52 Week High | CN¥5.60 |
| 52 Week Low | CN¥2.10 |
| Beta | 0.31 |
| 11 Month Change | 26.73% |
| 3 Month Change | -12.42% |
| 1 Year Change | -27.63% |
| 33 Year Change | 43.23% |
| 5 Year Change | 10.44% |
| Change since IPO | -30.76% |
Recent News & Updates
Shareholder Returns
| 000972 | CN Food | CN Market | |
|---|---|---|---|
| 7D | 17.5% | 3.3% | 0.4% |
| 1Y | -27.6% | -22.3% | -21.0% |
Return vs Industry: 000972 underperformed the CN Food industry which returned -22.3% over the past year.
Return vs Market: 000972 underperformed the CN Market which returned -21% over the past year.
Price Volatility
| 000972 volatility | |
|---|---|
| 000972 Average Weekly Movement | 7.6% |
| Food Industry Average Movement | 4.8% |
| Market Average Movement | 5.7% |
| 10% most volatile stocks in CN Market | 9.0% |
| 10% least volatile stocks in CN Market | 3.8% |
Stable Share Price: 000972 has not had significant price volatility in the past 3 months.
Volatility Over Time: 000972's weekly volatility (8%) has been stable over the past year, but is still higher than 75% of CN stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1994 | 585 | Wen Bo Mao | www.chalkistomato.com |
Chalkis Health Industry Co., Ltd. engages in the production, processing, and sales of tomatoes in China. It offers tomato paste, ketchup, sauce, and lycopene capsules. The company was formerly known as Xinjiang Chalkis Co., Ltd.
Chalkis Health Industry Co., Ltd Fundamentals Summary
| 000972 fundamental statistics | |
|---|---|
| Market cap | CN¥2.12b |
| Earnings (TTM) | CN¥97.34m |
| Revenue (TTM) | CN¥545.05m |
21.8x
P/E Ratio3.9x
P/S RatioIs 000972 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 000972 income statement (TTM) | |
|---|---|
| Revenue | CN¥545.05m |
| Cost of Revenue | CN¥410.29m |
| Gross Profit | CN¥134.76m |
| Other Expenses | CN¥37.42m |
| Earnings | CN¥97.34m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
Aug 31, 2024
| Earnings per share (EPS) | 0.13 |
| Gross Margin | 24.72% |
| Net Profit Margin | 17.86% |
| Debt/Equity Ratio | 173.6% |
How did 000972 perform over the long term?
See historical performance and comparison